Efficacy and Safety of Glecaprevir/Pibrentasvir in HCV Patients With Previous Direct-Acting Antiviral Therapy Failures: A Meta-Analysis

Background: Since a greater number of hepatitis C virus (HCV) patients have access to direct-acting antiviral (DAA) based therapies, the number of patients not properly responding to prior DAA regimens is increasing. The objective of this comprehensive analysis was to assess the efficacy and safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Chao, Fan, Haozhi, Ge, Zhijun, Cai, Weihua, Shao, Jianguo, Dong, Chen, Xue, Hong, Fu, Zuqiang, Li, Jun, Zhang, Yun, Yue, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793883/
https://www.ncbi.nlm.nih.gov/pubmed/33425940
http://dx.doi.org/10.3389/fmed.2020.592472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793883/
https://www.ncbi.nlm.nih.gov/pubmed/33425940
http://dx.doi.org/10.3389/fmed.2020.592472

Ejemplares similares